These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27556451)

  • 1. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
    Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei.
    dos Santos Ramos MA; Calixto G; de Toledo LG; Bonifácio BV; dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Nanomedicine; 2015; 10():7455-66. PubMed ID: 26719688
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    C de Lima L; A S Ramos M; Toledo LG; Rodero CF; Hilário F; Dos Santos LC; Chorilli M; Bauab TM
    Curr Pharm Des; 2020; 26(14):1556-1565. PubMed ID: 32183660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis.
    de Freitas Araújo MG; Pacífico M; Vilegas W; Dos Santos LC; Icely PA; Miró MS; Scarpa MV; Bauab TM; Sotomayor CE
    Med Mycol; 2013 Oct; 51(7):673-82. PubMed ID: 23758104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravaginal Delivery of
    Dos Santos Ramos MA; da Silva PB; de Toledo LG; Oda FB; da Silva IC; Dos Santos LC; Dos Santos AG; de Almeida MTG; Pavan FR; Chorilli M; Bauab TM
    J Biomed Nanotechnol; 2019 May; 15(5):1072-1089. PubMed ID: 30890237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis.
    Souza RO; Henrique de Lima T; Oréfice RL; de Freitas Araújo MG; de Lima Moura SA; Magalhães JT; da Silva GR
    J Pharm Sci; 2018 Oct; 107(10):2674-2685. PubMed ID: 29940181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.
    Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M
    Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
    de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
    J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis.
    Fabri RL; Freitas JCO; Lemos ASO; Campos LM; Diniz IOM; Pinto NCC; Silva TP; Palazzi C; Marchesini P; Monteiro C; Barbosa AF; Carvalho MG; Chedier LM; Araújo MGF; Apolônio ACM; Rocha VN; Melo RCN; Pinto PF
    Med Mycol; 2021 Dec; 59(12):1210-1224. PubMed ID: 34468763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro outcomes of quercetin on Candida albicans planktonic and biofilm cells and in vivo effects on vulvovaginal candidiasis. Evidences of its mechanisms of action.
    Tan Y; Lin Q; Yao J; Zhang G; Peng X; Tian J
    Phytomedicine; 2023 Jun; 114():154800. PubMed ID: 37043980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.